Kamel Debbi, MD

Henri Mondor University Hospital and Faculte de Medecin de Creteil Paris XII
Creteil, Ile-de-Fra

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 279 - Safety and Efficacy of Combined Trastuzumab-Deruxtecan and Concurrent Radiation Therapy in Breast Cancer: The TENDANCE Multicentric French Study (Trastuzumab-Deruxtecan and Concurrent Radiation Therap

  Tuesday, October 1, 2024
  1:05 PM – 1:15 PM ET